Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Gynecologic Cancer 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × gadobutrol × Gynecologic × Clear all
NCT04219904 2026-05-20

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
25 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04893434 2026-04-02

Novel Imaging Technique to Assess Gynecologic Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
24 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡